CRISPR
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts
Correcting Genetic Spelling Errors With Next-Generation Crispr
CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
Scribe Therapeutics becomes latest CRISPR company to announce layoffs
Editas, after slow start, outlines plan to catch other CRISPR companies
Integrating CRISPR and biomaterials engineering: Paving the way for safer gene therapies
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
Genetic Engineering
Genetic Engineering and the Endangered Species Act
A new era in genetic engineering: Researchers present single tool with multiple gene editing functions
Biotech Raises Are Breaking Records
The ethical and security implications of genetic engineering
Unlocking tomato regeneration: microRNA396's surprising role
Dallas company raises $200M for 'Jurassic Park-style' effort to bring back woolly mammoths
Breakthroughs in genetic engineering in 2024
Genetic Biocontrol Shortens Female Mosquito Lifespan to Fight Disease
Gene Editing
Could we ever regrow our adult teeth?
A new era in genetic engineering: Researchers present single tool with multiple gene editing functions
Beam Therapeutics: Too Expensive For Me, But Watch For Important Catalysts
Rice breeders explore gene editing to enhance nighttime heat tolerance
District Court: Factual Disputes Preclude Application of Safe Harbor to Gene Editing Technology at the Pleading Stage
Gene editing extends lifespan in mouse model of prion disease
Gene-edited soil bacteria could provide third source of nitrogen for corn production
CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths
CRISPR Therapy
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
Gene Therapy Market Size is Expected to Reach USD 29.24 Billion by 2033, Growing at a CAGR of 18.60%: Straits Research
'Will it really work?': Young sickle cell patient among the first to start new gene therapy
CRISPR biotech Intellia cuts staff as it eyes 2027 launch
New Approach Aims to Make CRISPR Therapy Safer and More Effective
Editas, after slow start, outlines plan to catch other CRISPR companies
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
HHS Calls Vertex's Case for Fertility Program a 'Distraction,' Urges Court to Rule in Its Favor
Biotechnology and Bioengineering News
CRISPR-based Gene Editing Market Report 2025, with Company Profiles of the Top 10+ Major Market Players
DNA
How Neandertal DNA May Affect the Way We Think
New Research Uncovers Long-Lived DNA Damage Linked to Cancer
No DNA clue found when widow died, court told
Death Row Inmate Tommy Zeigler's Attorneys Tout New DNA Evidence
Researchers uncover how PICH protein protects DNA during cell division
Scientists Discover RNA, Not DNA, Is Behind the Pain and Redness of Sunburn
Can DNA-nanoparticle motors get up to speed with motor proteins?
Man DNA tests Rescue Dog To Find Out What Breed He Is, Shocked by Results
Ancient DNA from graves reveals "jaw-dropping" discovery about Iron Age women in U.K., scientists say
DNA Sequencing
Seeing the unseen: New method reveals 'hyperaccessible' window in freshly replicated DNA
The bacterium that transformed DNA sequencing
How do DNA tests tell if two people are related?
An Entire Book Was Written in DNA—and You Can Buy It for $60
New Technology Uncovers DNA Secrets Behind Disease and Evolution
Global DNA sequencing market to witness 18.6% CAGR growth through 2029
Tagging gene-regulating DNA sequences with barcodes provides insights into human genome
BIOS flaws expose iSeq DNA sequencers to bootkit attacks
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
